招贤纳士

Kent Payne

感谢您对本公司的关注。 在保诺-桑迪亚,我们坚信团队热情和团队决心的重要性,及其对企业成功的影响力。

我们欢迎理解我们价值观,并能在一个不断创新、富有活力、快速成长和回报优厚的工作环境中茁壮成长的优秀人才。 请从以下职位中选择适合您的工作机会。如有任何问题,请随时与我们联系。

Kent M. Payne, PhD

首席执行官

我们的文化

Discovery
我们热爱我们的事业。 在保诺科技,我们相信我们的辛勤劳作能够改变未来。
Discovery
我们是一个大家庭,在平等和理解的基础上,充分维护对员工的尊重。
Discovery
我们坚韧不拔。 即使身处逆境,我们也绝不放弃,坚持就能胜利。
Discovery
我们重视结果。对于成功,我们有清晰的衡量标准,注重向内外利益相关者交付成功的结果。

津贴

Discovery
一个不断成长、持续发展,并在中美市场均已建立了领导地位的新兴行业。
Discovery
与拥有全球化背景、经验丰富的专家们互动交流。
Discovery
与亲密无间的团队携手合作,您的影响和贡献将得到充分重视。
Discovery
接触各地公司,通过合作网络发展广泛的伙伴关系。

请联系我们

Working hours

Monday- Thursday: 8:00-18:30 Hrs
(Phone until 17:30 Hrs)
Friday - 8:00-14:00

We are here

11011 Torreyana Rd. San Diego, CA 92121
Phone:+1 858.529.6600
Email: info@biodurolocal.local

当前工作机会

我们始终欢迎勤于思考、踏实肯干、 充满热情、不断探索和坚持信念的优秀人才。

请使用筛选器

  • Associate Director in in-vitro ADME

    Discovery Biology | Shanghai - CN

    关键活动

    Associate Director in in-vitro ADME

     

    Responsibility:

    • Lead or design, conduct and report in vitro ADME studies (absorption, distribution, metabolism and excretion) including assay designs, LC-MS/MS based bioanalytical method development, sample generation and sample analysis, data analysis, interpretation and reporting.
    • Develop new in vitro ADME assays as needed to address specific project or study issues, or new service capability.
    • Direct IND-enabling in vitro ADME studies including study protocol, report and writing and review according to regulatory technical guidelines (US FDA, China NMPA, EMA) under a GLP-like setting.
    • Serves as a DMPK representative on discovery and preclinical programs and initiatives; performing CYP450 and transporter mediated drug-drug interaction potential and in vitro – in vivo correlation analysis, ADME data interpretation and application.
    • Manage and supervise an in vitro ADME group; and collaborate with various functional DMPK groups,
    • Communicate effectively with clients for study update, project management and technical support.
    • Keeps up to date with emerging new mass spectrometric technologies, ADME assays such as transporters and regulatory technical guidelines.
    • Possess good interpersonal, oral and written communication skills.
    要求

    Qualifications

    • A M.S. or Ph.D. degree in drug metabolism, pharmaceutical science, organic chemistry, analytical chemistry, biochemistry, or related discipline with 8 – 12 years’ experience in pharmaceutical and biotechnological companies, or contract research organizations.
    • Hands-on experience in designing, conducting, analyzing and reporting in vitro ADME studies, including study designs, bioanalytical method development, sample generation and analysis, data analysis and reporting to support drug discovery and preclinical projects.
    • Working experience in quantitative LC-MS/MS method development and sample analysis with AB Sciex API LC-MS/MS and other vendors’ mass spectrometry systems; experience with high throughput autosamplers and programming automated liquid handlers.
    • Working experience in designing, conducting and reporting IND-enabling in vitro ADME studies to support regulatory filing (China NMPA, US FDA, EMA).
    • A thorough understanding of various small and large animal PK/TK studies are desirable.
    • Experience in leading and supervising a group of lab scientists.
    • Excellent oral and written communication, interpersonal, and organizational skills is required, along with demonstrated ability to interface effectively with clients and project team members in English and Chinese.

    提交简历

  • Director of PK and TK

    Discovery Biology | Shanghai - CN

    关键活动

    Director of PK and TK

     

    Responsibility: 

    • Lead to design, conduct and report pharmacokinetics (PK), toxicokinetics (TK), tissue distribution and excretion studies including study designs in small and large animals, LC-MS/MS bioanalytical method development, sample analysis, data modeling and analysis, reporting and interpretation.
    • Lead the bioanalytical method development and non-GLP validation of LC-MS/MS methods for discovery and regulatory PK/TK studies.
    • Direct IND-enabling PK/TK studies including study protocol, report and writing and review according to regulatory technical guidelines (US FDA, China NMPA, EMA) under a GLP-like setting.
    • Develop new PK assays as needed to address specific project or study issues, or new service capability.
    • Keeps up to date with emerging new mass spectrometric technologies, new animal surgery and formulation delivery technologies, and regulatory technical guidelines.
    • Communicate effectively with clients for study update, project management and technical support.
    • Communicate effectively with functional groups or departments. Set priority for the lab and allocate appropriate human resources/work schedule to ensure timely report delivery.

     

    要求

     

    Qualifications

    • A M.S., or Ph.D. degree in drug metabolism, pharmaceutical science, organic chemistry, analytical chemistry, biochemistry, or related discipline with 8 – 15 years’ experience in pharmaceutical and biotechnological companies, or contract research organizations.
    • Hands-on experience in designing, conducting, analyzing and reporting PK, TK, tissue distribution and excretion studies to support preclinical projects in discovery and GLP-like settings.
    • Working experience in designing and conducting IND-enabling PK/TK studies to support China and US NMPA regulatory filing in a GLP-like setting.
    • A thorough understanding in formulations, cassette-dosing, dose administration routes (oral, intravenous bolus and infusion, intraarterial, intramuscular, intraperitoneal, intratracheal, subcutaneous, transdermal, oropharyngeal aspiration, intrarectal, intranasal, etc.) and special delivery of test compounds in various small and large animal species (mice, rats, dogs, monkeys, rabbits, mini-pigs, etc.) and various surgery technologies (bile-duct cannulation, jugular cannulation, portal vein cannulation, carotid artery cannulation, etc.) in PK/TK studies.
    • Expertise in LC-MS/MS quantitation techniques including various MS/MS and LC platforms especially AB Sciex MS/MS, Shimazu and Waters HPLC/UPLC, bioanalytical method troubleshooting.
    • Experience in leading and supervising a group of lab scientists.
    • Excellent oral and written communication, interpersonal, and organizational skills is required, along with demonstrated ability to interface effectively with clients and project team members.

    提交简历

  • Group Leader/Senior Group Leader, In-Vitro ADME

    Discovery Biology | Shanghai - CN

    关键活动

    Group Leader or Senior Group Leader in in-vitro ADME

     

    Responsibility:

    • Lead or design, conduct and report in vitro ADME studies (absorption, distribution, metabolism and excretion) including assay designs, LC-MS/MS based bioanalytical method development, sample generation and sample analysis, data analysis, interpretation and reporting.
    • Develop new in vitro ADME assays as needed to address specific project or study issues, or new service capability.
    • Serves as a DMPK representative on discovery and preclinical programs and initiatives; performing CYP450 and transporter mediated drug-drug interaction potential and in vitro – in vivo correlation analysis, ADME data interpretation and application.
    • Manage and supervise an in vitro ADME group; and collaborate with various functional DMPK groups,
    • Communicate effectively with clients for study update, project management and technical support.
    • Keeps up to date with emerging new mass spectrometric technologies, ADME assays such as transporters and regulatory technical guidelines.
    • Possess good interpersonal, oral and written communication skills.

     

     

    要求

    Qualifications

    • A M.S. or Ph.D. degree in drug metabolism, pharmaceutical science, organic chemistry, analytical chemistry, biochemistry, or related discipline with 5 – 10 years’ experience in pharmaceutical and biotechnological companies, or contract research organizations.
    • Hands-on experience in designing, conducting, analyzing and reporting in vitro ADME studies, including study designs, bioanalytical method development, sample generation and analysis, data analysis and reporting to support drug discovery and preclinical projects.
    • Working experience in quantitative LC-MS/MS method development and sample analysis with AB Sciex API LC-MS/MS and other vendors’ mass spectrometry systems; experience with high throughput autosamplers and programming automated liquid handlers.
    • Familiar with IND-enabling in vitro ADME studies to support regulatory filing (China NMPA, US FDA, EMA).
    • A thorough understanding of various small and large animal PK/TK studies are desirable.
    • Experience in leading and supervising a group of lab scientists.
    • Excellent oral and written communication, interpersonal, and organizational skills is required, along with demonstrated ability to interface effectively with clients and project team members in English and Chinese.

    提交简历

  • Associate Director of Chemistry

    Advanced - CN | Wuxi-CN | 化学

    关键活动

     Responsibility:

    Lead Group Leaders and Bench scientists to execute chemistry projects well, to build and maintain positive relationship with clients by providing on-time and high-quality delivery and proactive communications.

     

    • Set up the scientific and operational goal and SOP for the projects assigned; manage and coach Group Leaders and bench scientists; manage resources and control the cost effectively.
    • Proactively participate the Business Development activities with self-initiative or under the assignment from the supervisor.
    • Recruit, train and coach key members of the team, maintain positive morale in the team by setting objective, performance management and people management.
    • As a member of the company’s Sr. Management team, play an active and important role in building and maintaining the company culture, the company’s reputation in the industry by participating internal and external communication events.
    要求
    • PhD. in synthetic organic chemistry or medicinal chemistry with more than 8 years of drug discovery and managerial experience (experience in the U.S. or EU preferred)
    • Successful track record in medicinal chemistry with extensive patent and publication records
    • Ability to operate within aggressive timelines
    • Deep understanding of the pharmaceutical R&D process
    • Strategic thinker with the ability to manage a fast-growing business
    • Flexible and innovative problem solver

    提交简历

  • Director/Associate Director of Chemistry

    Advanced - CN | Beijing - CN | 化学

    关键活动

    Responsibility:

     

    Lead Group Leaders and Bench scientists to execute chemistry projects well, to build and maintain positive relationship with clients by providing on-time and high-quality delivery and proactive communications.

     

    • Set up the scientific and operational goal and SOP for the projects assigned; manage and coach Group Leaders and bench scientists; manage resources and control the cost effectively.
    • Proactively participate the Business Development activities with self-initiative or under the assignment from the supervisor.
    • Recruit, train and coach key members of the team, maintain positive morale in the team by setting objective, performance management and people management.
    • As a member of the company’s Sr. Management team, play an active and important role in building and maintaining the company culture, the company’s reputation in the industry by participating internal and external communication events.
    要求
    • PhD. in synthetic organic chemistry or medicinal chemistry with more than 8 years of drug discovery and managerial experience (experience in the U.S. or EU preferred)
    • Successful track record in medicinal chemistry with extensive patent and publication records
    • Ability to operate within aggressive timelines
    • Deep understanding of the pharmaceutical R&D process
    • Strategic thinker with the ability to manage a fast-growing business
    • Flexible and innovative problem solver

    提交简历

  • Director/Associate Director of Biologics

    Advanced - CN | Beijing - CN | Biologics

    关键活动
    • Act as the leader of BioDuro’s therapeutic antibody discovery and engineering teams with clients, and lead internal antibody programs.
    • Able to give scientific input and act as biologics leader within cross-functional project teams to evaluate, prioritize and set strategy to positively influence project direction and timelines.
    • Accountable for driving, growing and expanding Biologics teams, as well as communicating with clients, maintain and enhance client relationships, and work with BD to build up new clients.
    要求
    • Ph.D. /MD Ph.D. in molecular biology, and cell biology, biochemistry, pharmaceutical sciences, or equivalent.
    • At least 6+ years industry experiences in therapeutic antibody discovery and engineering area, with expertise in immunology, oncology.
    • Experience of hiring, leading and managing in biological teams.
    • Excellent communication skills and can work as a team player
    • Able to effectively collaborate and drive towards scientific goals in a dynamic, cross-functional matrix environment.

     

    提交简历

  • Biocore Scientist

    Shanghai - CN

    关键活动

    We’re seeking an experienced Biacore scientist to support the assay development and sample analysis for both small molecule and biologics drug discovery in the biophysics group at BioDuro.

    1. Hands-on scientific expertise and problem-solving skills in Biacore analysis, and co-ordinate with project teams to streamline the sample characterization process.
    1. Performs Biacore instrumentation routine maintenance, and fully document all protocols and results in notebook and compose summary report.
    要求
    1. MS 2+ years of work experience, preferably in industrial settings.
    2. Extensive knowledge and expertise in Biacore technology and SPR applications, and proven hands-on skills in biomolecular interaction analysis or ligand-binding assay (ELISA, e.g.).
    1. Experience with fragment-based screening using SPR or other biophysical methods is highly desirable. Work experience in GLP invironment, as well as practical knowledge in bioanalytical assays is also desirable.
    1. Strong organization and communication skills, and the ability to work in a team environment.
    1. Fluent oral and written English, and strong literature-searching ability.

    提交简历

  • Group Leader of Bioanalysis

    Shanghai - CN

    关键活动

    1. Conduct bioanalytical method development using LCMSMS
    2. Conduct bioanalysis work for PK samples and in vitro ADME samples
    3. Perform PK parameter calculation using WinNonlin software and write study report
    4. Communicate with supervisor about study progress and issues
    5. Peer review other scientists’data
    6. Acting as a project leader and ensure project is delivered error-free and in timely fashion

    要求
    1. MS in Analytical chemistry, Pharmaceutical Science or Pharmacology
    2. Working experience of modern LCMSMS is a must
    3. 5 year experience in DMPK study with at least 2 years management experience.

    提交简历

  • Group Leader of Bioanalysis

    Shanghai - CN

    关键活动
    1. Conduct bioanalytical method development using LCMSMS
    2. Conduct bioanalysis work for PK samples and in vitro ADME samples
    3. Perform PK parameter calculation using WinNonlin software and write study report
    4. Communicate with supervisor about study progress and issues
    5. Peer review other scientists’data
    6. Acting as a project leader and ensure project is delivered error-free and in timely fashion
    要求
    1. MS in Analytical chemistry, Pharmaceutical Science or Pharmacology
    2. Working experience of modern LCMSMS is a must
    3. 5 year experience in DMPK study with at least 2 years management experience.

    提交简历

  • Senior Director/Director/Associate Director, Medicinal Chemistry

    Shanghai - CN

    关键活动

    Responsibility:

    Lead Group Leaders and Bench scientists to execute chemistry projects well, to build and maintain positive relationship with clients by providing on-time and high quality delivery and proactive communications.

    • Set up the scientific and operational goal and SOP for the projects assigned; manage and coach Group Leaders and bench scientists; manage resources and control the cost effectively.
    • Proactively participate the Business Development activities with self-initiative or under the assignment from the supervisor.
    • Recruit, train and coach key members of the team, maintain positive morale in the team by setting objective, performance management and people management.
    • As a member of the company’s Sr. Management team, play an active and important role in building and maintaining the company culture, the company’s reputation in the industry by participating internal and external communication events.
    要求
    • D. in synthetic organic chemistry or medicinal chemistry with more than 10 years of drug discovery and managerial experience (experience in the U.S. or EU preferred)
    • Successful track record in medicinal chemistry with extensive patent and publication records
    • Expertise in drug targets including GPCR, kinase, ion channel and other enzyme targets is desired. Familiarity with structure-based design is a plus
    • Ability to operate within aggressive timelines
    • Deep understanding of the pharmaceutical R&D process
    • Strategic thinker with the ability to manage a fast-growing business
    • Flexible and innovative problem solver

    提交简历

  • Senior Group Leader/Associate Director of Discovery Biology

    Discovery Biology | Shanghai - CN

    关键活动

    Division/Department: Discovery Biology

    Line Manager’s Title: Senior Director of Discovery Biology

    Location: Shanghai

    Responsibility:

    • Lead a team of in vitro biology scientists to develop, optimize, validate and execute biochemical and/or cellular assays to support drug discovery projects, including assay development, and running assays for SAR support and compound profiling
    • Ability to supervise a team to meet project timelines and teach directly writing of assay reports and trouble shooting skills

    The individual is expected to have good communication skills, especially be capable of communicating effectively in English both in writing to communicate project progress and sharing data and in verbal communication to discuss project progress, interpret and present data to clients and the other BioDuro project team representatives

    要求
    • A Ph.D degree in Biochemistry, Molecular Biology, Cell Biology or immunology with at least 1-5 years post-doctoral research experience, preferably in drug discovery industry or CRO
    • Solid background and training in his or her own fields of studies and in conducting research using the latest drug discovery technologies and advances in science
    • Preference will be given to candidates with good knowledge and experience in Oncology, Inflammation, Immunology and ImmunoOncology drug discovery areas
    • Supervisory experience is required
    • Good oral and written communication skills in English (proficiency in Chinese preferred)

    提交简历

  • Director, Oncology

    Oncology | Shanghai - CN

    关键活动

    The position is a research leader role with proven organizational & management skill. A team of scientists reporting to this leader will be responsible for contract preclinical research/CRO service in cancer pharmacology and immunooncology related projects.

     

    Responsibilities:

    • As a technical leader, work independently or lead a team to execute multiple internal or external projects;
    • Interact with clients on the service introduction, study protocol, update and report preparation etc.
    • Supervise lab scientists and junior staff
    要求
    • PhD in cancer biology, cell biology, immunology or oncology (or comparable), 10+ years of relevant experience with 2+ industry experience
    • Familiar with various in vitro cell-based and in vivo cancer pharmacology studies
    • Responsible and organized
    • Strong communication and interpersonal skills
    • Good verbal and written English
    • Good at troubleshooting and creative problem-solving

    提交简历

  • Director: Discovery Biology

    Discovery Biology | Shanghai - CN

    关键活动

    We are seeking a highly experienced and innovative molecular or cell biologist who will join us as Director of Discovery Biology at BioDuro (Shanghai site). The successful candidate will lead a diverse team of biologists and protein scientists, and will be responsible for all in vitro biochemical and cellular assays, in vitro safety pharmacology studies, and production of biological reagents, including effectively developing and managing all related service contracts. The individual will be expected to drive innovation and develop new enabling capabilities within Discovery Biology, and interact closely with other functions including the biophysics, DMPK and in vivo pharmacology teams.  The successful candidate should have excellent written and oral communication skills, strong leadership experience, and the ability to prioritize options, anticipate challenges, and execute on goals in a fast-paced and customer-oriented environment.

    Key responsibilities include but are not limited to the following:

    • Builds and leads a high-performance in vitro biology team, provides effective mentorship and performance management. Ensures delivery on top financial and productivity goals and maintenance of customer satisfaction.
    • Fosters transparent and supportive communications with clients, project teams, and internally with other cross-functional business units and stake-holders. Technical support for BD work with quotations and contract discussions.
    • Manages the design, validation, and execution of all in vitro biochemical and cell-based assays for diverse classes of drug targets and drug modalities, including mechanistic and phenotypic functional assays as well as various cytotoxicity assays. Ultimately responsible for assay quality, data records, timely and authoritative reporting/interpretation of experimental results to clients or project teams.
    • Manages the timely delivery on high quality recombinant protein production and stable cell line generation.
    • Leads the identification and utilization of current and emerging technologies that are critical to expand BioDuro capabilities and fulfill customer needs in cutting-edge drug discoveries.
    • Ensures proper training and full compliance of EHS rules and government regulations for all members of the Discovery Biology department.
    要求

    Education and Work Experience Requirement:

    • Ph.D. in molecular biology, cell biology, biochemistry, enzymology, or a related scientific discipline with 12+ years of work experience, preferably in a Biotech/Pharmaceutical/CRO setting

    Required Experience:

    • Demonstrated deep expertise in various in vitro biochemical and cell-based assays.
    • Broad experience in drug discovery and in supporting SAR studies of diverse classes of drug targets.
    • In-depth knowledge and experience in certain disease areas (e.g. immunology, oncology or metabolic diseases) is highly desirable.
    • Expertise in mechanistic enzymology and protein chemistry, and familiarity with major biophysical and bioanalytical techniques (e.g. SPR, ITC or MS) is highly desirable.
    • A successful track record of managing a relevant business unit at a CRO is a strong plus.

    提交简历

  • Assistant Director, Oncology

    Oncology | Shanghai - CN

    关键活动

    The position is a research leader role with proven organizational & management skill. A team of scientists reporting to this leader will be responsible for contract preclinical research/CRO service on cancer pharmacology and immune-oncology related projects.

    Responsibilities:

    • As a technical leader, work independently or lead a team to execute multiple internal or external projects;
    • Interact with clients on the service introduction, study protocol, update and report preparation etc.
    • Supervise lab scientists and junior staff
    要求
    • PhD or MD in cancer biology, cell biology, immunology or oncology (or comparable), 7+ years of relevant experience with 2+ industry experience
    • Familiar with various in vitro cell-based and in vivo cancer pharmacology studies
    • Strong responsibility and organization skill
    • Strong communication and interpersonal skill
    • Good verbal and written English
    • Good at troubleshooting and creative problem-solving

    提交简历

  • Senior Scientist of Immunology / Cell Biology

    Biologics | Shanghai - CN

    关键活动

    Exciting opening in a brand new team that will focus on the most recent technology of cell based immunotherapy. The ideal candidate will be trained and working directly with top scientists from an international Pharma, lead and manage his/her own group to conduct research in Cancer Immunotherapy field. The title will be based on the actual experience of candidates.

    要求

    The candidate is expected to meet the following requirements:

    PhD in immunology, neurobiology, cell and molecular biology, biotechnology, biochemistry, genetics or any other relevant areas.

    1. Analytical, detail-oriented, organized, efficient, problem-solver, adaptable, independent but also works well in a cross-functional team
    2. Strong experience in mammalian cell culture, cell transduction/transfection techniques, and analysis
    3. Highly Desired:
    4. Primary human immune cell isolation and culture (T cell, NK cell, etc.)
    5. Experience with cytoxicity assays (ADCC, CDC, etc.) and cytokine release assays
    6. Lentiviral transduction
    7. FACS based analysis
    8. ELISA
    9. English: speaking fluent English, strong in writing and record keeping.

     

    提交简历

  • Sr. Scientist of Animal Pharmacology

    Pharmacology | Shanghai - CN

    关键活动

    Exciting opening in a brand new team that will focus on the most recent technology of cell based immunotherapy. The ideal candidate will be trained and working directly with top scientists from an international Pharma, lead and manage his/her own group to conduct research in Cancer Immunotherapy field. The title will be based on the actual experience of candidates.

    要求

    The candidate is expected to meet the following requirements:

    PhD in immunology, neurobiology, cell and molecular biology, biotechnology, biochemistry, genetics or any other relevant areas / experience.

    1. Analytical, detail-oriented, organized, efficient, problem-solver, adaptable, independent but also works well in a cross-functional team
    2. Able to communicate plans and results effectively in English and Mandarin
    3. Strong experience in designing and running animal models to evaluate efficacy of novel cancer therapeutics, animal husbandry / experimentation, and sample size determination for statistical significance

      Highly Desired:

    • Experience with human xenograft cancer models (cell lines. PDX) in immunocompromised mice (ex. NSG mice)
    • Experience with tail vein injection of immune cells into mice
    • Experience with subcutaneous and peritoneal cancer models
    • Experience with in vivo optical imaging technology to follow disease progression and cell trafficking with bioluminescent and fluorescent probes ((Xenogen IVIS, LI-COR, etc.)
    • Experience with chimeric antigen receptor in vivo studies
    • English: speaking fluent English, strong in writing and record keeping.

    提交简历

  • 总监/副总监,药物化学

    上海 | 化学

    关键活动

    领导一个组长团队和替补科学家执行化药项目,建立并通过提供及时和高质量的交付和积极主动的沟通与客户保持积极的关系。

    • 设置指定项目的业务目标和SOP;管理和教练组长跟替补科学家;管理资源并有效地控制成本。
    • 积极主动拓展业务领域及配合上级拓展业务。
    • 招聘,培训和训练团队的主要成员。通过设定目标,绩效管理和人员管理维护增强团队士气。
    • 作为公司的高级管理团队中的一员,在建设和维护公司的文化、公司在同行中的名望,通过参与内部和外部沟通活动中发挥积极和重要的作用。

    汇报对象: 高级总监,药物化学

    地点: 上海

    要求
    • 博士,有机合成化学和药物化学专业,8年以上药物研发或管理经验(美国或欧洲优先)
    • 在相关的药物靶标,包括GPCR,激酶,离子通道和其他酶的目标专业领域精通。熟悉基于结构基础设计者优先。
    • 熟悉CRO业务和运营
    • 能在有限的时间节点交付
    • 对制药研发行业有深刻的理解
    • 战略的眼光管理快速增长的业务
    • 灵活和创新的解决问题
    • 在药物化学领域有夯实的经验且有广泛的专利和出版记录

    提交简历

无位置可用

David Preston
David Preston

Chairman

David Preston has had 38 years of healthcare experience with publicly – Traded and Private companies in the fields of Pharmaceutical’s, Animal Health and Biotechnology as a Board Member. The last 30 years of his experience has been in China, Taiwan and Hong Kong building successful high growth businesses. David Has been Chairman and CEO for Greater China for Sanofi and Boehringer – Ingelheim as well as the Janssen Corporation since 1991 in China. During this time he built high Growth businesses in China through diversified strategies in Innovative Pharmaceuticals, branded Generics, Biotechnology, and Animal Healthcare.


Key highlights in this period included building of the first Western Multinational Biotechnology C.M.O. facility as well as obtaining the first Test C.M.O.[ MAH] license. Establishment of a number of High tech Vaccine Plants, and R and D facilities in the field of Animal Health. Signing and development of numerous JV’s as well as Wholly owned  Subsidiaries, Mergers and Acquisitions across Pharmaceutical’s, Animal Health, and Biotechnology industries.

 

David’s achievements in the Healthcare industry and it Growth and development in China is widely recognized by the Chinese Government and the City of Shanghai. In 2013 he was awarded the Silver Magnolia followed in 2015 the Gold Magnolia award. This was then followed by being awarded in 2017 the Honorary Citizen of Shanghai by 40th People’s Municipal Congress of Shanghai. David holds a Business Science Degree 

This will close in 0 seconds

Filippo
Filippo de Vecchi

Director, Advent Partner

Filippo de Vecchi joined Advent in February 2000. He started in the Advent São Paulo office, then moved to Milan in 2002, in 2012 set up the Advent office in Shanghai and in 2016 set up the Hong Kong office. Before joining Advent, he was a senior consultant with Value Partners, in São Paulo and Milan, focusing on strategy and organization in the automotive, energy, cable and media sectors. He began his career at Wasserstein Perella & Co., working as an analyst in the Mergers and Acquisitions department in London and New York. Filippo holds an undergraduate degree cum laude in Economics, with a major in Business Administration, from the LUISS University and an MBA from Columbia Business School, where he currently serves as a member of the Board of Overseers.

This will close in 0 seconds

Andrew Li
Andrew Li

Director, Advent Partner

Andrew Li joined Advent in 2012. He previously worked at Warburg Pincus, HSBC PE, Solera Capital and Credit Suisse where he focused on the retail and consumer, healthcare, industrial, and energy sectors. Andrew has worked in finance and private equity throughout the U.S. and China since 1999. Andrew holds a BA from Middlebury College and an MBA from Harvard Business School.

This will close in 0 seconds

Michael Miltenberger
Michael Miltenberger

Director, Advent Partner

Michael Miltenberger joined Advent in 2011 as an associate in the healthcare team. Following business school, he rejoined Advent’s Boston office, focusing on healthcare investments. Prior to Advent, Michael was a consultant at McKinsey & Company in their Washington DC office, serving a range of healthcare and private equity clients. Michael earned a BA, cum laude, from Harvard College and an MBA from Harvard Business School, graduating with High Distinction as a Baker Scholar and a Harvey Fellow.

This will close in 0 seconds

Masood Tayebi
Masood Tayebi, PhD

Director, Operating Partner

Dr. Masood Tayebi is the Founder of BioDuro. He currently serves as CEO of a nationwide real estate portfolio and is a Partner and Chief Executive Officer of the Bridgewest Group. Prior to BioDuro, Dr. Tayebi was Co-Founder and Chairman of Wireless Facilities, Inc. (NASDAQ: WFI), a global leader in telecommunications outsourcing.

Achievements
  • Co-Founder of Wireless Facilities, Inc.
  • Co-Founder of BioAtla, LLC
  • Recipient of the Ernst and Young 2000 Entrepreneur of the Year award in San Diego

This will close in 0 seconds

Kewen Jin
Kewen Jin, PhD

Director, Operating Partner

This will close in 0 seconds

Amit patel
Amit Patel

Director, Operating Partner

Amit Patel has twenty years of healthcare industry experience with publicly-traded, private equity-backed, and start-up companies in the capacity of executive, board member, advisor, and investor.  He is currently Executive Chairman of Azurity Pharmaceuticals (a NovaQuest Capital Management portfolio company) and a board member at BioDuro (Advent International portfolio company), Tergus Pharma (Great Point Partners portfolio company) and Calyptus Pharma.  Recently, Amit was SVP & President of Dosage Form Solutions at Capsugel, a KKR portfolio company (purchased from Pfizer in 2011 and sold to Lonza in 2017).


Prior to Capsugel, he worked at Dr. Reddy’s Laboratories, Inc. as EVP & Head of North America, and SVP & Head of Global Corporate Development & Strategic Planning. Earlier, Amit was VP of Corporate Development at CTIS, Inc., and Co-founder & CEO of MedOnTime, Inc. (acquired by CTIS).  He started his career as a strategy consultant with Marakon Associates. Amit holds an M.B.A. degree from Harvard Business School, a B.S. degree in Economics from the Wharton School of Business, University of Pennsylvania, and a B.A.S. degree in Systems Engineering from the Moore School of Engineering, University of Pennsylvania

This will close in 0 seconds

Haijun Dong
Haijun Dong

Chief Executive Officer

Dr. Haijun Dong currently serves as global CEO of BioDuro-Sundia. He previously was CEO for over 5 years at PharmaBlock Sciences Inc., a public company listed in the Shenzhen Stock Exchange (300725.SZ). The positions he held prior to PharmaBlock includes, among others, Senior Scientist at Boehringer Ingelheim Pharmaceuticals in Ridgefield, Connecticut; Senior Principal Scientist at Roche in Nutley, New Jersey; Head of DMPK and Drug Safety at Roche China R&D Company in Shanghai; Chief Operating Officer of Eli Lilly China R&D Center in Shanghai.

Dr. Dong received his PhD in organic chemistry from the University of Washington in Seattle, Washington, and MBA from China Europe International Business School in Shanghai. 

This will close in 0 seconds

Teo Nee Chuan
Teo Nee Chuan

Chief Financial Officer

Teo Nee Chuan joined us in May 2021 as chief financial officer. Prior to joining us, he was chief financial officer of Huazhu Group from November 2015 to May 2021, and was the chief financial officer for Rnomac International Limited, from November 2011 to August 2015. Mr. Teo worked in DDB Greater China Group, was appointed as the chief financial officer in September 2009, and was additionally appointed as the director of operations in January 2011. He previously served in Focus Media Group and was appointed as the financial deputy director in June 2007. Prior to that, from September 1994 to May 2007, Mr. Teo worked at Ernst & Young and Ernst & Young Business Services Ltd. in various positions in Kuala Lumpur and Toronto, including as a senior manager in the Transaction Advisory Services. Mr. Teo has been an independent director of 111, Inc. (a company listed on the NASDAQ, ticker symbol: YI) since September 2018. Mr. Teo received his Bachelor of Science in Accounting and Financial Analysis degree from The University of Warwick in the United Kingdom in July 1994. He is a Chartered Certified Accountant in the United Kingdom, who has obtained his qualification in July 1998 from The Association of Chartered Certified Accountants, and is a Certified Public Accountant in the United States and Hong Kong, who has obtained his qualification from American Institute of Certified Public Accountants in May 2002 and Hong Kong Society of Accountants in October 2003, respectively.

This will close in 0 seconds

TJ
TJ Deng, PhD

President, Discovery

Dr TJ Deng joined BioDuro in the initial stages of the company and helped BioDuro grow to an industry leading discovery services organization. He established and managed several scientific departments, including DMPK, before transitioning to a leader of the business and operations functions. Prior to joining BioDuro, Dr. Deng spent six years at PPD, in positions with increasing responsibilities from scientist to scientific manager.

Achievements

 

 

  • Developed the extractable/leachable capabilities at PPD
  • 18 years industry experience

This will close in 0 seconds

Kent Payne
Kent M. Payne, PhD

President, Global CMC Solutions

Kent is distinguished as a business operator and leader in areas of sales, commercial manufacturing and product development. He has extensive executive experience in M&A as well as successfully running, start up, growth and turn around businesses. This includes both Fortune 500 and Private Equity environments. He combines strong business leadership, successful P&L track record, and technical background to strategically lead and grow enterprise value across Biotechnology and Pharmaceutical market segments. He has successfully led the geographic expansion of businesses into Europe, Asia, South America in addition to the United States.

He also currently serves as a board member for Goodwin Biotechnologies (a biological contract manufacturer), and board advisor for Vitruvias Therapeutics (a specialty generic pharmaceutical business)

Achievements

  • CEO Socorro Pharmaceuticals, a generic pharmaceutical company
  • President Americas, Qualicaps Inc.
  • Principal Consultant and Partner at CoreFactor LLC, providing executive strategic, licensing and operational advisory services to clients.
  • Vice President/General Manager Catalent Pharma Solutions, Inc. (a Blackstone Group company formed in 2007, formerly part of Cardinal Health)
  • Progressive leadership responsibility at: Novartis, Monsanto and G.D. Searle.
    Prior Board Positions:
  • Board Advisor, Corporate Strategy Office, Life Science Institute Inc. (a wholly-owned subsidiary of Mitsubishi Chemical Holdings.
  • Board member for Technophar, Inc.; Qualicaps, Inc.
  • Non-executive Chair and Board Member PDS Biotechnology (PDS

This will close in 0 seconds

Tommy Broudy
Tommy Broudy, PhD

Executive Vice President, Marketing

Tommy Broudy joined BioDuro as Executive Vice President, Translational Sciences in 2018 following the acquisition of Molecular Response, a patient-derived tumor modeling company he cofounded in 2010. Tommy is now leading BioDuro’s translational oncology group, with focus on in vivo and in vitro oncology testing services that help more efficiently translate novel anti-cancer medicines into the clinic. Tommy previously served as General Manager of Crown Bioscience San Diego, where he led the US preclinical operation. Prior to that, Tommy served as Director at AltheaDx, working closely with the Business Development and R&D teams to establish gene expression-based companion diagnostics for oncology therapeutics. He also spent six years at Affymetrix, where he managed the company’s pharmacogenomic and toxicogenomic solutions in support of pharmaceutical R&D.

Achievements

 

  • Earned his PhD at Rockefeller University in the Laboratory of Bacterial Pathogenesis and Immunology
  • Held postdoctoral appointments at Rockefeller and Stanford University studying host/microbial genomics

This will close in 0 seconds

Roy Xu
Roy Xu

Chief Strategy Officer

Roy has over 25 years of healthcare industry experience.  He started his career as an orthopedic surgeon.  Roy joined Eli Lilly as a sales rep in 1997.  Since then he has had various roles in market research, business intelligence, BU head, strategy, regional general management, business development etc., both at Eli Lilly and Boehringer Ingelheim (BI).  Roy also spent more than two years in Germany where he was BI’s Director of Corporate Business and Enabling Strategy.

Roy obtained a bachelor’s degree in Clinical Medicine at Zhejiang Traditional Chinese Medicine University, and an MBA from Zhejiang University.

Achievements

 

  • 25 years of healthcare industry experience including Eli Lily and Boehringer Ingelheim. 
  • Former Director of Corporate Business & Enabling Strategy at oehringer Ingelheim in Germany.

This will close in 0 seconds

San Diego/圣地亚哥

BioDuro- San Diego Facility

Our San Diego site is our corporate headquarters. The facility is home to BioDuro’s drug product development technologies and has 9 GMP clean rooms. Development and manufacturing operations are conducted for projects up to Phase III clinical trials.

Size: 44,000 sq. ft.
Featured capabilites: Tableting, Coating, Hot Melt Extrusion, Spray Dried Dispersion

11011 Torreyana Rd.
San Diego
CA 92121
United States

This will close in 0 seconds

Beijing/北京

BioDuro Beijing
Operating since 2006, our Beijing site is home to BioDuro’s first wet chemistry operations. With 300 regular fume hoods and 18 scale-up chemistry hoods the Beijing facility houses most of BioDuro’s chemistry operations, while also hosting labs for biology and monoclonal antibody discovery.

Size: 100,000 sq. ft. 
Featured capabilities: Radioactivity Lab, Monoclonal Antibody Discovery, Medicinal Chemistry

No. 29 Life Science Park Road
Changping District Beijing,
102206
P.R. China

This will close in 0 seconds

Shanghai-Waigaoqiao/上海-外高桥

BioDuro- Shanghai Facility

Established in 2012, BioDuro’s Shanghai facility has been growing with its departments. The cutting edge facility contains labs for ADME, bioanalysis, in vitro assays and translational research. The site includes a 18,000 sq. ft vivarium and 20,000 sq. ft of office space.

Size: 92,000 sq. ft.
Featured capabilities: Scale-up Chemistry, Discovery Biology, DMPK, In Vivo Pharmacology

No. 233 North Fu Te Road
Waigaoqiao Free Trade Zone
Shanghai, 200131
P.R. China

This will close in 0 seconds

Cathy Yen
Cathy Yen

Director, Operating Partner

Cathy joined the Board of Directors of BioDuro-Sundia in 2020, with the Advent-led acquisition of Sundia and creation of BioDuro-Sundia. Prior to that, she was Chairman of the Board at Sundia Meditech Group, where she was the key architect of Sundia’s strategic vision and growth. Under her leadership, Sundia solidified its position as one of the leading pre-clinical CROs in China.

Prior to Sundia, Cathy had a distinguished career as a seasoned venture capitalist, having led numerous investments in high-growth companies in Asia. Cathy served as a Partner of AsiaVest Partners, TCW/YFY Ltd., a global venture capital firm, for over a decade, Vice President at Global Financial Services, Vice President at Crimson Ventures/Chinatrust Bank and Senior Manager at Fortune Capital. She brings over 20 years of experience in corporate finance, accounting, strategic planning and private equity investments.

This will close in 0 seconds

Wuxi/无锡

Wuxi - BioDuro

Established in 2019, BioDuro-Sundia’s fully integrated discovery facility located at the heart of Jiangsu Wuxi Life Science & Technology Industrial Park with plans of growing staff to 1000+ scientists

Size: 300,000 sq. ft.
Featured capabilities:
Discovery Chemistry & Biologics, Biology, DMPK, Pharmacology, CMC Services

no.1699,Huishan avenue

Huishan Economic 

Development Zone,Wuxi

P.R. China

This will close in 0 seconds

Hebei/河北

Hebei - Sundia
Established in 2011, this pilot plant this handles mg to kg scale up

Size: 45,208 sq. ft.

Featured capabilities: SFFS Chemistry: mg to kg scale up
(150 hood)

238 Changjiang Road

Shijiazhuang,

Hebei province
P.R. China

This will close in 0 seconds

Taiwan/台湾

Taiwan Sundia
Our site in Taiwan supports Discovery Biology and Chemistry

Size: 3,352sq.ft.
Featured capabilities: Chemistry;Biology

7F, No. 107, Sec. 4

Ren Ai Road,

Da-an District,

Taipei, Taiwan

This will close in 0 seconds